Many fine articles on salicinium have been published in the Townsend Letter in 2013, 2014, 2015, 2016, 2017, and 2022 are available in the Archives. I would like to present a brief overview of my journey in the world on integrative oncology using salicinium and my current perspective on the task of successful problem solving for cancer patients.
The field of integrative oncology is a new frontier for medical problem solving. Cancer is the epidemic no one is talking about. Even five year “disease free” survival is increasingly difficult to achieve. We are seeing a huge increase in new cases of first-time diagnosis at Stage IV cancer in patients under the age of 35. Worldwide hope for a “cure” remains paramount in patient consciousnesses, yet even disease-free survival is difficult to attain despite our advances in drug development and technology. When we look at the traditional treatment options of chemotherapy, radiation therapy, surgery, hormonal modulation, and immunotherapy, these modalities continue to evolve. Nonetheless, many patients are seeking treatment outside of these options.










0 Comments